Volume 3.33 | Sep 2

Immunology of Infectious Disease News 3.33 September 2, 2015
Immunology of Infectious Disease News
     In this issue: Publications | Reviews | Industry News | Policy News | Events | Jobs
Like Us on Facebook  IIDN on Twitter
 
TOP STORY
Infection with Multiple HIV-1 Variants Leads to Poorer Clinical Outcomes
HIV-1 infection with multiple founder variants points to poorer clinical outcomes than infection with a single variant. Researchers analyzed large sample sets from two important HIV vaccine efficacy trials to evaluate whether genetic characteristics of the founder viral populations could influence markers of clinical outcomes. [Press release from the US Military HIV Research Program discussing online prepublication in Nature Medicine] Press Release | Abstract
Learn more about T cell activation and expansion with ImmunoCult™
 
PUBLICATIONS (Ranked by impact factor of the journal)
Innate Immunological Function of TH2 Cells In Vivo
While type 2 innate lymphoid cells are the dominant innate producers of interleukin 13 in naive mice, investigators found that helminth-infected mice had more type 2 helper T cells (TH2 cells) cells compared to uninfected mice, and these cells became major mediators of innate type 2 responses. [Nat Immunol] Abstract

Counter Inhibition between Leukotoxins Attenuates Staphylococcus aureus Virulence
Researchers demonstrated that the leukotoxins LukSF-PV and LukED antagonize each other’s cytolytic activities on leukocytes and erythrocytes by forming inactive hybrid complexes. [Nat Commun] Full Article

Twenty-Eight Years of Poliovirus Replication in an Immunodeficient Individual: Impact on the Global Polio Eradication Initiative
The authors describe an individual who has been excreting type 2 vaccine-derived poliovirus for twenty eight years as estimated by the molecular clock established with VP1 capsid gene nucleotide sequences of serial isolates. Using a range of in vivo and in vitro assays they show that the viruses are very virulent, antigenically drifted and excreted at high titer suggesting that such chronic excreters pose an obvious risk to the eradication program. [PLoS Pathog] Full Article | Press Release

Halothane Modulates the Type I Interferon Response to Influenza and Minimizes the Risk of Secondary Bacterial Pneumonia through Maintenance of Neutrophil Recruitment in an Animal Model
The authors demonstrated that halothane mitigates the risk of secondary bacterial pneumonias postflu through modulation of the effects of type I interferon. [Anesthesiology] Abstract | Press Release

Myeloid-Related Protein 8 Induces Self-Tolerance and Cross-Tolerance to Bacterial Infection via TLR4- and TLR2-Mediated Signal Pathways
Scientists report that myeloid-related protein 8 (Mrp8) triggered TNF-α and IL-6 release via a Toll-like receptor 4 (TLR4)-dependent manner. Pre-stimulation of murine macrophages and human monocytes with Mrp8 induced self-tolerance to Mrp8 re-stimulation and cross-tolerance to lipopolysaccharide, bacterial lipoprotein, gram-negative and gram-positive bacterial challenges, with substantially attenuated TNF-α and IL-6 release. [Sci Rep] Full Article

The Contribution of Chlamydia-Specific CD8+ T Cells to Upper Genital Tract Pathology
Investigators evaluated whether antigen-specific CD8+ T cells mediate chlamydial pathology. Chlamydia-specific interferon-γ and tumor necrosis factor -α production from purified splenic CD8+ T cells of OT-1 mice was minimal, whereas responses in OT-1 mice replete with wild type (WT) CD8+ T cells were comparable to those in WT animals. [Immunol Cell Biol] Abstract

Borrelia burgdorferi Elongation Factor EF-Tu Is an Immunogenic Protein during Lyme Borreliosis
Researchers studied the immunogenicity, surface localization, and function of B. burgdorferi elongation factor Tu (EF-Tu). They found that EF-Tu is highly immunogenic in mice, and EF-Tu antibodies were readily detected in Lyme disease patients. [Emerg Microbes Infect] Full Article

HIV

Cell-to-Cell Transmission of HIV-1 Is Required to Trigger Pyroptotic Death of Lymphoid-Tissue-Derived CD4 T Cells
Researchers showed that cell-to-cell transmission of HIV is obligatorily required for activation of this death pathway. Cell-free HIV-1 virions, even when added in large quantities, fail to activate pyroptosis. [Cell Rep] Full Article | Graphical Abstract | Press Release

Adenosine Deaminase Regulates Treg Expression in Autologous T Cell-Dendritic Cell Cocultures from Patients Infected with HIV-1
As regulatory T cells produce the immunomodulatory molecule adenosine, investigators aimed to assess the potential of adenosine removal to revert the suppression of anti-HIV responses exerted by regulatory T cells. [J Leukoc Biol] Abstract

HIV-1 Protease Cleaves the Serine-Threonine Kinases RIPK1 and RIPK2
Scientists found that receptor-interacting protein kinase 1 (RIPK1) and RIPK2 but not other members of the RIP kinase family are cleaved by HIV-1 protease. RIPK1 and RIPK2 were cleaved during HIV-1 infection of T cell lines or primary activated CD4+ T cells. [Retrovirology] Full Article

Higher Frequency of NK and CD4+ T-Cells in Mucosa and Potent Cytotoxic Response in HIV Controllers
Researchers evaluated the frequency, phenotype and activity of T and NK cells in peripheral blood and gut mucosa in a cohort of Colombian HIV controllers. Gag-stimulated CD8+ T-cells and cytokine-stimulated NK cells were tested for cytotoxic activity. [PLoS One] Full Article

Subscribe to our sister publications: Human Immunology News and Immune Regulation News!

Isolate particle-free human CD4+CD127lowCD25+ regulatory T cells (Tregs) in less than one hour. Request a sample today.
 
REVIEWS
Middle East Respiratory Syndrome Coronavirus: Transmission, Virology and Therapeutic Targeting to Aid in Outbreak Control
Currently, no drug has been clinically approved to control Middle East respiratory syndrome coronavirus (MERS-CoV) infection. The authors highlight the potential drug targets that can be used to develop anti-MERS-CoV therapeutics. [Exp Mol Med] Full Article

Visit our reviews page to see a complete list of reviews in the Immunology of Infectious Disease research field.
 
INDUSTRY NEWS
Northwestern, Partners Launch AIDS Research Center to Stop HIV
A new five-year, $6.25 million grant from the National Institutes of Health will help investigators from Northwestern University, the University of Chicago and others across the city of Chicago work together to slow and stop HIV. [Northwestern University] Press Release

UC San Diego Scientists Investigate Global Hemorrhagic Fever Bacterial Disease
An international research team, headed by Joseph Vinetz, MD has been awarded a 5-year, $1.89 million cooperative agreement to carry out translational research studies of leptospirosis, an infectious and sometimes fatal bacterial disease endemic in much of the world. [UC San Diego Health] Press Release

NIBSC Develops New-CE Marked Virus Triplex for NAT PCR Blood Testing – HBC, HCV, HIV
NIBSC announced the availability of a very low positive triplex reagent (NIBSC Code 14/198) for NAT assays containing hepatitis B (HBV), hepatitis C (HCV) and human immunodeficiency virus-1 (HIV-1). [National Institute for Biological Standards and Control (NIBSC)] Press Release

From our sponsor: Working with blood? Download the immune cell frequencies app.
 
POLICY NEWS
National Institutes of Health (United States)

Food and Drug Administration (United States)

Center for Biologics Evaluation and Research (United States)

European Medicines Agency (European Union)

Medicines and Healthcare Products Regulatory Agency (United Kingdom)

Therapeutic Goods Administration (Australia)
 
EVENTS
NEW Pathology 2015
December 1-3, 2015
London, United Kingdom

Visit our events page to see a complete list of events in the Immunology of Infectious Disease community.
 
JOB OPPORTUNITIES
NEW Postdoctoral Position – Immunology and Virology (Herman B Wells Center for Pediatric Research)

NEW Faculty Positions – Virology (NYU School of Medicine)

NEW Postdoctoral Scientist – Innate and Adaptive Immune Response to S. Aureus Infection (Cedars-Sinai)

PhD Positions – Infection Biology and Immunology (ZIBI Graduate School)

Postdoctoral Position – HIV Vaccine Immunology (Dana-Farber Cancer Institute)

Postdoctoral Fellow – Molecular Microbiology/Immunology (The University of Tennessee)

Postdoctoral Fellowship – Viral Immunology (Emory University)

Research Assistant – Immunotherapy for HIV Infection (California Institute of Technology)


Recruit Top Talent: Reach more than 60,000 potential candidates by posting your organization’s career opportunities on the Connexon Creative Job Board at no cost.
 

Have we missed an important article or publication in Immunology of Infectious Disease News? Click here to submit!

Comments or suggestions? Submit your feedback here
Learn more about Immunology of Infectious Disease News: Archives | Events | Contact Us